TITANOREINE

Symptomatic treatment of painful and pruriginous anal manifestations, especially in the hemorrhoidal attack.

If symptoms do not give way to rapid or worsening symptoms, stop use and a procedure should be performed and treatment should be reviewed.

Patients with rectorragia or blood in the stool should talk to their doctor before using this product, as they may be symptoms of a more serious underlying pathology.

Pharmacotherapeutic group

OTHER MEDICINAL PRODUCTS FOR THE TREATMENT OF HEMORROIDES AND ANAL FISHING WITH TOPIC USE, ATC code: C05AX04.

Mucoprotective and lubricant of the ano-rectal mucosa, it protects it from mechanical and chemical aggressions due mainly to the stercoral contacts.

Carraghenate (Rhodophycated Algae Extract) provides in wet environment a colloidal mucilage, filmogenic, likely to apply intimately to the inflamed or damaged mucosa and to the stool which it facilitates the slip and the need for evacuation.

Furthermore, the carraghenate keeps in contact with the mucous membrane other inert and protective topical components.

Adverse reactions identified with carraghenates, titanium dioxide and zinc oxide are classified by frequency using the following classification: very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1000 to < 1/100); rare (≥ 1/10000 to < 1/1000), very rare (< 1/10000), not known (cannot be estimated from the available data).

System Organ Frequency Adverse reaction

Skin and subcutaneous tissue disorders Unknown Prurit, rash Immune system disorders Unknown Hypersensitivity Reporting suspected adverse reactions Reporting suspected adverse reactions after authorization of the drug is important and allows for ongoing monitoring of the benefit/risk ratio of the drug.

Health care professionals report any suspected adverse reactions via the national reporting system: National Drug and Health Products Safety Agency (NSMA) and the Network of Regional Pharmacovigilance Centres.